Optimal TARGETs for cardiovascular safety and benefit in ESRD.
Sane
David C
DC
D002118:Calcium / Q000097:blood; D002318:Cardiovascular Diseases / Q000209:etiology; D000069449:Cinacalcet; D004359:Drug Therapy, Combination; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000188:drug therapy*; D006996:Hypocalcemia / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy*; D009281:Naphthalenes / Q000008:administration & dosage* / Q000009:adverse effects; D010281:Parathyroid Hormone / Q000097:blood; D012449:Safety; D013261:Sterols / Q000008:administration & dosage / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage* / Q000009:adverse effects
D009281:Naphthalenes; D010281:Parathyroid Hormone; D013261:Sterols; D014807:Vitamin D; D002118:Calcium; D000069449:Cinacalcet